Latest News

Date Title Topic
27 Apr 2015 FDA Approves Ramucirumab for Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
24 Apr 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Nivolumab Melanoma - Cancer Immunology and Immunotherapy
22 Apr 2015 Pembrolizumab Shows Antitumour Activity in Patients with Advanced NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
21 Apr 2015 Phase III Randomised Trial Shows Pembrolizumab Superiority When Compared to Ipilimumab in Patients with Advanced Melanoma Melanoma - Cancer Immunology and Immunotherapy
Consensus Guidelines Locally-advanced stage III non-small-cell lung cancer (NSCLC)
17 Apr 2015 ELCC 2015 News: Circulating Tumour Cells May Be a Prognostic Marker for Disease Recurrence Following Radical Resection in Patients with NSCLC Translational research - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: One in Four Advanced Lung Cancer Patients Tested for EGFR Mutations Started on First-line Treatment Before Test Results Available Bioethics, legal and economic issues - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: DNA Blood Test Detects Lung Cancer Mutations Translational research - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: Smokers Underestimate Risks of a Few Cigarettes Epidemiology/Etiology/Cancer Prevention - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: Evidence Grows that Melanoma Drugs Benefit some Lung Cancer Patients Lung and other thoracic tumours - Anticancer agents & Biologic therapy
16 Apr 2015 ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC Personalised medicine - Translational research - Lung and other thoracic tumours
16 Apr 2015 ELCC 2015 News: Neoadjuvant Erlotinib in Endobronchial Ultrasound Confirmed Stage IIIA-N2 NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
16 Apr 2015 ELCC 2015 News: Promising Results for Surgical Salvage of Local Recurrences after Stereotactic Ablative Radiotherapy in Patients With Early-Stage NSCLC Personalised medicine - Translational research - Lung and other thoracic tumours
16 Apr 2015 ELCC 2015 News: VEGF SNPs Identified as Prognostic Markers for Bevacizumab Response in Patients with Advanced Non-Squamous NSCLC Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy